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Omenn syndrome (OS) is an inherited disorder 
characterized by the paradoxical coexistence of 
immunodeficiency and autoimmunity. OS is a 
genetically heterogeneous condition caused by 
a variety of genetic defects impairing lympho-
cyte development (Villa et al., 2008). Affected 
patients  manifest  with  symptoms  of  severe 
combined immunodeficiency (SCID), includ-
ing an increased occurrence of life-threatening 
infections, failure to thrive, and, in particular, 
autoimmune-like clinical features including 
early-onset  severe  erythrodermia,  alopecia, 
hepato-splenomegaly, and lymphadenopathy 
(Omenn, 1965; Ochs et al., 1974). The best-
characterized defects leading to OS are hypo-
morphic mutations in RAG genes, the first 
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Hypomorphic RAG mutations, leading to limited V(D)J rearrangements, cause Omenn syn-
drome (OS), a peculiar severe combined immunodeficiency associated with autoimmune-like 
manifestations. Whether B cells play a role in OS pathogenesis is so far unexplored. Here we 
report the detection of plasma cells in lymphoid organs of OS patients, in which circulating  
B cells are undetectable. Hypomorphic Rag2R229Q knock-in mice, which recapitulate OS, 
revealed, beyond severe B cell developmental arrest, a normal or even enlarged compartment 
of immunoglobulin-secreting cells (ISC). The size of this ISC compartment correlated with 
increased expression of Blimp1 and Xbp1, and these ISC were sustained by elevated levels  
of T cell derived homeostatic and effector cytokines. The detection of high affinity patho-
genic autoantibodies toward target organs indicated defaults in B cell selection and tolerance 
induction. We hypothesize that impaired B cell receptor (BCR) editing and a serum B cell 
activating factor (BAFF) abundance might contribute toward the development of a patho-
genic B cell repertoire in hypomorphic Rag2R229Q knock-in mice. BAFF-R blockade reduced 
serum levels of nucleic acid-specific autoantibodies and significantly ameliorated inflamma-
tory tissue damage. These findings highlight a role for B cells in OS pathogenesis.
© 2010 Cassani et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months–   
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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inflammatory response, ultimately leading to tissue damage and 
autoimmunity (Münz et al., 2009). Such a process may be   
favored in OS patients, in part because of defaults in the cellu-
lar and molecular components responsible for keeping inflam-
mation in check (Villa et al., 2008).
Here,  we  have  investigated  the  central  and  peripheral   
development of B cells in Rag2R229Q mice, their function, as 
well as their contribution to the OS immunopathology. Our 
results show that in the presence of a severe BM B cell devel-
opmental defect, homeostatic and effector cytokines sustain 
the peripheral expansion of a few “nonconventional” ma-
ture, activated B cells, which engender a relatively increased 
compartment of Ig-secreting cells (ISCs). The resulting pe-
ripheral B cells are responsive to TLR agonists and T cell–
independent  antigens.  We  demonstrate  that  sera  from 
Rag2R229Q mice contain high-affinity anti-dsDNA and tissue-
specific autoantibodies. Rag2R229Q B cells display impaired 
receptor editing, and mutant mice have increased serum 
BAFF levels. Notably, BAFF-mediated rescue of autoreac-
tive B cell clones was prevented by selective BAFF-R block-
ade, resulting in significant amelioration of tissue damage. 
Collectively, these findings point to an as yet unrecognized 
role of B cells in the OS immunopathology.
RESULTS
Detection of plasma cells in lymphoid organs of OS patients
OS patients are characterized by oligoclonal T cells, although 
they are virtually devoid of circulating B cells (Fig. 1 A and 
Table S1). However, high IgE and residual IgG and/or IgM 
serum levels indicate that Ig-producing plasma cells are ac-
tively present. Histological analysis of LN biopsies from two 
OS patients revealed a severe alteration of the microscopic 
architecture of the organ characterized by expansion of the 
paracortical area, along with severe depletion of the lymphoid 
cell population and lack of B cell follicles (Fig. 1 B, top left). 
Late B cell differentiation stages, including plasma cells and a 
subset of GC B cells, which are committed to plasma cell dif-
ferentiation (Angelin-Duclos et al., 2000), are characterized 
by the expression of both Blimp1 and CD138, or Blimp1 
alone, respectively. Accordingly, LN biopsies from healthy 
donors revealed the presence of a relatively small number of 
Blimp1+CD138– late GC B cells, as well as Blimp1+CD138+ 
terminally differentiated plasma cells (Fig. 1 B, top right and 
inset). We detected Blimp1+CD138+ double-positive cells in 
both LN biopsies from OS patients, albeit at different levels 
(Fig. 1 B, bottom left and right). However, in contrast to 
LNs from healthy donors, Blimp1+CD138– cells were only 
occasionally detected (unpublished data). Thus, in LNs from 
OS patients with undetectable circulating B cells, the large 
majority of Blimp1+ cells represent an advanced stage of 
plasma cell differentiation.
We analyzed BM samples from four OS patients bearing 
RAG mutations for B cell subset composition. As expected 
from the recombinase defect, a severe block in B cell differen-
tiation was evident, and mature B cells were barely detectable 
(Fig. 1 C). To better characterize this developmental arrest, we 
players in V(D)J recombination (Villa et al., 1998, 1999). The 
hallmark of OS, as a consequence of residual recombinase ac-
tivity, is a peculiar immune phenotype made up of normal or 
elevated numbers of activated yet poorly functional T cells, 
with a highly restricted oligoclonal TCR repertoire. Such   
T cells infiltrate various organs, including skin, gut, spleen, 
and liver, resulting in profound tissue damage (Harville et al., 
1997; Rieux-Laucat et al., 1998; Signorini et al., 1999). More 
recently, we and others have reported hypomorphic Rag 
mouse mutants that mimic many features of human OS (Khiong 
et al., 2007; Marrella et al., 2007); the study of these mice has 
led to a better understanding of the complexity of OS patho-
genesis. Together, these models have clearly demonstrated 
that, in lymphopenic conditions, abnormal compensatory pe-
ripheral T cell proliferation and reduced thymic output could 
favor the expansion of T cell clones with inappropriate self-
reactivity, and predispose to the development of immuno-
pathology. Moreover, the lack of thymic Aire expression and 
the markedly reduced number of Foxp3+ regulatory T cells 
suggested  that  impairment  in  both  central  and  peripheral 
mechanisms of tolerance may contribute toward the devel-
opment of autoimmunity both in mice (Marrella et al., 2007) 
and in humans (Poliani et al., 2009; Cassani et al., 2010).
In contrast, the B cell defect still remains one puzzling as-
pect of OS. Most of the OS patients have high IgE and resid-
ual IgG and/or IgM serum levels, though are virtually devoid 
of circulating B cells. On the other hand, later studies have 
shown that hypomorphic RAG mutations can, indeed, be as-
sociated with milder B cell phenotypes and, in such cases, Ig 
may be variably present (Villa et al., 2001; Sobacchi et al., 
2006). The basis for this broad clinical spectrum is largely un-
known, but epigenetic and environmental factors may play a 
causative role. Consistent with these observations, spontane-
ous hypomorphic Rag1 mutant mice showed high serum lev-
els not only of IgE but also of IgG and IgM isotypes. In the 
periphery, partial B cell maturation occurred, displaying a re-
stricted BCR repertoire. Moreover, B cells in these mice re-
sponded to antigen challenge and T cell help, in agreement 
with the presence of functional germinal centers (GCs; Khiong 
et al., 2007). In contrast to the leaky B cell defect in this mu-
rine model, B cell differentiation seemed more heavily af-
fected in Rag2R229Q mice, similar to patients with typical OS 
(Noordzij et al., 2002). Indeed, a severe arrest at the pro–B 
stage was evident in the BM and was associated to a dearth of 
mature functional B lymphocytes in the peripheral lymphoid 
organs, which are depleted of B cell follicles (Marrella et al., 
2007). Analogous to archetypal OS, the origin of elevated   
serum IgE levels in these mice remains to be elucidated.
Several lines of evidence led us to hypothesize that defects 
in RAG-mediated Ig gene editing/revision, either in the BM 
or in peripheral lymphoid tissues, might contribute to the de-
velopment of the autoimmune phenotype (Hillion et al., 2005; 
Wang and Diamond, 2008). In addition to genetic susceptibil-
ity, autoreactive B cells can arise from the inability of a defec-
tive immune response to eradicate environmental pathogens. 
This results in a compensatory, often exaggerated chronic   JEM VOL. 207, July 5, 2010 
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used the differential expression of marker molecules to define 
various stages of B cell differentiation (van Zelm et al., 2005). 
In the BM from age-matched healthy children, 18% of   
the precursor B cell compartment consisted of cytoplasmic 
(Cy) Ig cells, whereas in BM from all analyzed OS pa-
tients, 92% (82–98%) of the precursor B cell compartment 
had this phenotype (Fig. 1 D). Interestingly, some CyIg+ pre–
B-II cells and surface membrane (Sm) IgM+ immature B cells 
could be detected in patients OS4 and OS5 (Fig. 1 D). The 
mature B cell population (CD19+ SmIgM+ SmIgD+) was dra-
matically reduced in patients (<0.6% vs. 24% in healthy con-
trols; unpublished data). However, ELISpot analysis revealed 
the presence of ISCs in the BM of all OS patients, producing 
either IgM or IgG/A (Fig. 1 E).
Characterization of BM and splenic B cell compartment  
in Rag2R229Q mice
Given the obvious limitation in performing experiments with 
tissue samples from OS patients, we addressed the role of   
B cells in the pathogenesis of Rag2R229Q mice, which recapitu-
late the main immune system alterations observed in OS pa-
tients (Marrella et al., 2007). Indeed, similarly to the majority 
of patients, Rag2R229Q mice showed absent or dramatically re-
duced numbers of circulating B cells (Fig. 2 A), which is in-
dicative of arrested B cell development. In the BM, Rag2R229Q 
mice had a significantly reduced absolute number and per-
centage of B220+ B cells (P < 0.0001; Fig. 2 B and Fig. S1 A). 
Analysis of early B cell subsets showed a severe block in B cell 
differentiation at the pro–B cell stage, as indicated by the   
selective  increase  of  early  pro–B  cells  (B220+CD43+IgM– 
HSAlowBP-1–; Hardy et al., 1991; P = 0.03; Fig. S1 A and   
not depicted) and the severely reduced pre–B cells (B220+ 
CD43–IgM–), as well as IgM+IgD– immature B cells (P < 0.0001; 
Fig. 2 B and Fig. S1 A). As a consequence, the absolute number 
and relative proportion of splenic B220+ B cells were pro-
foundly reduced in Rag2R229Q mice (P < 0.0001; Fig. 2, C and D, 
and Fig. S1, B and C), with the complete absence of conven-
tional transitional (T1 and T2) and mature B cells (Fig. 2 C and 
Fig. S1 B). The peripheral B cell pool was mainly composed 
of IgM+IgD– B cells, half of which expressed B220 (43.8 ± 
12.3%; Fig. 2 C, bottom), and were negative for the AA4.1 
and CD138 markers (not depicted). Notably, the expression 
of several cell activation markers (CD40, CD69, CD86, and 
MHC II) was augmented in B220+IgM+ cells from Rag2R229Q 
mice when compared with the same subset from WT littermates 
Figure 1.  Analysis of the B cell compartment in OS patients.  
(A) Peripheral blood mononuclear cells were stained with anti-CD19 mAb 
and analyzed by flow cytometry in two independent experiments. FACS 
plots of one representative age-matched healthy donor (HD) and two OS 
patients with RAG mutations are shown. Numbers indicate percentage of 
cells. (B) Representative LN biopsies from HD and two OS patients have 
been stained by H&E and double immunostained with anti-CD138 and 
Blimp1. Bars: (top left) 200 µM; (top right and bottom left and right) 100 µM. 
(C) BM-derived mononuclear cells from patients and healthy donors were 
stained with anti-CD19, -CD24, and -CD38 mAbs. FACS plots shown are 
gated on CD19+ cells. Numbers indicate percentage of cells for each sub-
set. (D) Composition of the precursor B cell compartment in OS patients 
(n = 4) compared with age-matched healthy children (n = 9). The BM 
precursor B cell compartment was set at 100% after exclusion of CD10/
SmIgM+/SmIgD+ mature B cells. (E) Frequency of ISCs in cultures of IgM 
and IgG-IgA isotypes. The number of spots/105 CD19+ B cells is reported. 
ELISpot analysis was performed once in two independent experiments.
 1528 B cells in the pathogenesis of Omenn syndrome | Cassani et al.
(Fig. 2 C). Among IgM+ B cells, the mature naive splenic   
B cell compartment is made up of two populations designed 
as follicular (FO) B cells (B220+CD23highCD21low) and mar-
ginal zone (MZ) B cells (B220+CD23lowCD21high). Rag2R229Q 
mice had barely detectable IgM+ MZ B cells and lacked ma-
ture IgD+ FO B cells (Fig. 2 D and Fig. S1 C), consistent with 
the almost complete disruption of both MZ and FO organiza-
tion (not depicted). In contrast, a CD21–CD23–B220+ lym-
phocyte population was overrepresented in the mutant mice 
in comparison with WT littermates (P = 0.0037; Fig. S1 C). 
The CD21–CD23– cells were CD43–/lowCD5–Mac-1– and 
negative for sIg (not depicted), thus excluding the conven-
tional B-1 lineage. These findings collectively suggest that in 
Rag2R229Q mice some B cells may overcome the developmen-
tal block and colonize the periphery.
The  presence  of  peripheral  B  cells  in  Rag2R229Q  mice 
prompted us to analyze the IgH repertoire. To this end, we 
cloned and sequenced the cDNAs encoding the Ig heavy chain 
(IgH) variable domain of IgM from bulk sorted B220+ spleno-
cytes (Table S2). The analysis of these sequences showed one 
dominant set of clonally related cells (CRCs) in each of the 
mutant mice, whereas we found only four small CRC clusters 
in the WT animal (Fig. S2 A). We additionally performed   
single-cell PCRs on individually sorted B220+CD19+ spleno-
cytes of WT and Rag2R229Q mice. Again, although we could 
not find CRCs in the normal mice, two out of three Rag2R229Q 
animals showed CRC clusters (Fig. S2 A). The absence   
of CRCs from Rag2R229Q B220+CD19+ B cells in the third 
sorting experiment is likely caused by the small number of   
sequences analyzed. Although we could not definitely demon-
strate that Rag2R229Q mice display a restricted Igh-V repertoire 
(Fig. S2 B), the results from single-cell PCR show expansion 
of a few CRCs in Rag2R229Q mice.
ISC expansion in secondary lymphoid organs  
of Rag2R229Q mice
With high variability, the production of serum IgG1, IgG2, 
and IgM was preserved in Rag2R229Q mice (aged 1–9 mo), 
whereas IgG3 and IgA were reduced (P < 0.0001; Fig. 3 A). 
Consistent with the OS phenotype, IgE levels were signifi-
cantly higher in mutant mice (P < 0.0001). Thus, Rag2R229Q 
mice are able to produce serum Ig of all isotypes, in spite of 
Figure 2.  Characterization of the B cell compartment in Rag2R229Q 
mice. (A) Analysis of circulating B cells from WT and Rag2R229Q mice.  
(B) Total BM cells were labeled with anti-B220, CD43, IgM, and IgD to 
determine B cell developmental stages. Representative FACS plots are 
shown for mice (WT = 35 and Rag2R229Q = 42) analyzed in six independent 
experiments. Numbers indicate percentage of cells for each gate. (C) Dot 
plots show analysis of splenic mature and transitional B cell populations 
from WT and Rag2R229Q mice, using IgD and IgM markers. Histograms 
show expression of CD40, CD86, CD69, and MHCII activation markers in 
gated splenic B220+ IgM+ cells. Numbers indicate percentage of cells  
for each gate. (D) Splenocytes were labeled with anti-B220, -CD21,  
and -CD23 and analyzed by flow cytometry. Dot plots are gated on B220+ 
cells. Numbers indicate percentage of cells for each gate. The results shown 
are representative of mice (WT = 43 and Rag2R229Q = 57) analyzed in  
six independent experiments.
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sorted B220+ cell pool, these findings suggest that splenic B cells 
from Rag2R229Q mice might have progressed further through a 
plasmacytic differentiation pathway than those of WT mice. 
Accordingly, in mutant mice, Xbp1 and Blimp1 expression 
were further increased in B220IgM+ B cells with respect to 
B220+IgM+ B cells, indicative of an advanced stage of plasma 
cell differentiation (unpublished data). Furthermore, Rag2R229Q 
B220+ cells retained increased expression of Aid (P = 0.029; 
Fig. 3 C), which is essential for somatic hypermutation and iso-
type switching/class switch recombination (CSR).
Activated effector/memory T lymphocytes sustain ISC 
expansion, but do not help an antigen-specific response  
in Rag2R229Q mice
B cell activation and plasmacytic differentiation might be co-
operatively sustained by T cell activation. In Rag2R229Q mice, 
CD4+ T cells were skewed toward TH-1 polarization, as in-
dicated by increased production of IFN-, but not of IL-4 and 
 IL-10 cytokines upon PMA/ionomycin stimulation (Fig. 4 A). 
Interestingly, CD4+ T cells from Rag2R229Q mice had a substan-
tially increased percentage of IL-17–producing cells (Fig. 4 A). 
Accordingly,  Rag2R229Q  CD4+  T  cells  displayed  signifi-
cantly  increased  mRNA  levels  for  the  Th1-specific   
T-bet transcription factor and reduced mRNA levels for 
GATA-3, which directs Th2 polarization (P = 0.03; Fig. 4 D; 
Szabo et al., 2002). Significantly higher mRNA levels for the 
Th17-specific RORt transcript were also detected. Thus, 
Th1 and Th17 cells could be implicated in the inflammatory 
condition characteristic of Rag2R229Q mice.
Th17  cells  se-
crete large amounts 
of IL-21, which then 
acts  to  amplify  the 
the apparent lack of mature B cells. To clarify this apparent 
discrepancy, we enumerated ISCs in cell suspensions derived 
from BM, spleen, and LNs by ELISpot. Using this analysis, 
we found a greater proportion of ISCs in secondary lym-
phoid organs of all Rag2R229Q mice assayed compared with 
WT mice (Fig. S3 A). More pronounced differences were 
scored when ISC counts were normalized to B cell numbers. 
Indeed, mutant mice displayed 6–165-fold increases in IgM-, 
IgG-, IgA-, and IgE-secreting cells within the B cell com-
partment of spleen and LNs, compared with WT littermates 
(IgM, IgG, IgA, P = 0.008; IgE, P = 0.028; Fig. 3 B). In 
contrast, in the Rag2R229Q BM, ISCs were retrieved to a lesser 
extent and with higher variability (Fig. 3 B). This observation 
correlated  with  the  reduced  expression  of  CXCL12  in 
Rag2R229Q BM, the chemokine required for plasma cells 
homing and survival in BM niches (Tokoyoda et al., 2004; 
Fig. S3 B). These data revealed a larger expansion of the ISC 
population in Rag2R229Q mice, mainly within the secondary 
lymphoid organs.
Plasmacytic differentiation is sustained by a program of gene 
expression, of which Blimp1 is considered to be the primary 
trigger (Martins and Calame, 2008). By quantitative PCR, we 
found that expression of Blimp1 is increased by threefold in 
splenic B220+ B cells isolated from mutant mice as compared 
with controls (P = 0.029; Fig. 3 C). Increased Blimp1 expres-
sion also resulted in the induction of Xbp1, which is required 
for antibody production and secretion (Reimold et al., 2001;   
P = 0.029; Fig. 3 C). Differentiation to ISC with Blimp1 up-
regulation is associated with transcriptional repression of Bcl6 
and c-Myc, characteristic of GC B cells (Lin et al., 1997; Shaffer 
et al., 2000). Accordingly, these transcripts were significantly 
reduced in Rag2R229Q B220+ cells (P = 0.029; Fig. 3 C). There-
fore,  although  partially  limited  by  the  heterogeneity  of  the 
Figure 3.  Serum Ig levels and ISC in lym-
phoid organs. (A) Sera from naive WT (n = 49) 
and Rag2R229Q (n = 67) mice (5–37 wk-old) 
were collected and their IgG1, IgG2a, IgG2b, 
IgG3, IgM, and IgA concentrations were deter-
mined by luminex technique using a Bioplex 
reader. Each serum sample was run in dupli-
cate, and five independent assays were per-
formed. Serum IgE concentrations were 
measured by ELISA in five independent experi-
ments. (B) The frequency of IgM-, IgG-, IgE-, 
and IgA-secreting cells in the BM, spleen,  
and LNs of naive WT and Rag2R229Q mice  
(10–12 wk old) was determined by ELISpot. The 
number of spots/105 B220+ cells is indicated. 
Results are mean ± SD of five independent 
experiments testing a total of 17 mice/group. 
(C) Transcriptional programming sustains ISC 
differentiation in Rag2R229Q mice. B220+ lym-
phocytes were purified by cell sorter from 
total splenocytes of WT (n = 6) and Rag2R229Q 
mice (n = 12). Expression levels of different 
transcription factors were normalized to 18S 
rRNA. Quantitative RT-PCR was run in tripli-
cates. Relative measures are indicated as  
arbitrary units (A.U.). Data represent one of 
the three independent experiments with  
consistent results. *, P < 0.05; **, P ≤ 0.01;  
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serum level in Rag2R229Q mice (Fig. 5 C) and a substantial 
decrease in the concentrations of CSR-driving cytokines, 
IFN- and IL-21 (Fig. 5 D). Thus, these findings highlight 
the contribution of CD4+ T cells in sustaining B cell activa-
tion and plasma cell differentiation in Rag2R229Q mice.
We  next  investigated  whether  Rag2R229Q  mice  could 
mount a T cell–dependent immune response in vivo. Mutant 
and WT mice (10 wk of age) were immunized into the foot-
pad with OVA in CFA and boosted with recall antigen in 
immunofluorescence (IFA) on day 21. At regular intervals, 
sera were analyzed simultaneously for total and OVA-specific 
antibodies.  As  expected,  in  normal  mice  immunization   
resulted in a rapid and significant increase of total IgG serum 
levels (P = 0.03; Fig. 6 A and not depicted), whereas no IgG 
elevation was observed in Rag2R229Q mice (Fig. 6 A). More-
over, in WT animals OVA-specific IgG levels were detect-
able immediately after the boost and sustained after 48 d   
(Fig. 6 B). In contrast, we could not detect a secondary anti-
OVA IgG response in the sera from Rag2R229Q mice (Fig. 6 B). 
These results were matched by the analysis of the frequency 
of antigen-specific ISC as measured by ELISpot. Unimmunized 
Rag2R229Q mice made significantly more IgG-secreting cells 
than WT mice (P = 0.008; Fig. 6 C). However, after boost-
ing, an increased number of IgG plasma cells were detectable 
exclusively in the spleens of WT mice (P = 0.029) from days 
26 to 33, and returned to nearly baseline levels by day 48, 
which is consistent with the IgG serum levels (Fig. 6 C). A simi-
lar trend was observed in the response of WT mice using the 
ELISpot assay (Fig. 6 D). No OVA-specific IgG-secreting cells 
could  be  detected 
in  the  Rag2R229Q 
mice at any of the 
time points assayed 
(Fig. 6 D), indicating 
Th17 response in an autocrine fashion (Korn et al., 2007; 
Zhou et al., 2007). Analysis of serum cytokines by ELISA 
revealed  that  mutant  mice  had  elevated  levels  of  IL-21   
(P = 0.0113) and IFN- (P = 0.0007; Fig. 4 B). Because pro-
duction of both IL-17 and IL-21 cytokines has been associ-
ated to FO helper T cells (TFH cells; Bauquet et al., 2009; 
Chtanova et al., 2004), in addition to TH-17 cells, we ana-
lyzed the CD4+ T cell subset for the expression of CXCR5 
and ICOS, crucially involved in TFH cells homing and dif-
ferentiation (Schaerli et al., 2000; Mak et al., 2003). An in-
creased proportion of ICOS+ cells was observed in Rag2R229Q 
CD4+ splenocytes (41.6% vs. 7.7%; n = 6; P = 0.008), and 
more CD4+ ICOShi T cells expressed CXCR5 in Rag2R229Q 
mice (7.7% vs. 1.5%; n = 6; P = 0.008; Fig. 4 C). Rag2R229Q 
CD4+ CXCR5+ ICOShi T cells expressed WT levels of 
CD40L, but increased levels of programmed death-1 (PD-1;   
Fig. S4), both of which are co-stimulatory molecules nec-
essary for TFH cell generation and function (Vinuesa et al., 
2005). The mRNA encoding the transcription factor Bcl6, 
a determinant of the TFH cell fate (Nurieva et al., 2009),   
was also significantly increased in Rag2R229Q CD4+ spleno-
cytes (P = 0.03; Fig. 4 D). Overall, these data define subsets 
of  T  helper  cells  with  the  potential  to  activate  B  cells   
and  promote  their  differentiation  into  ISC  in  Rag2R229Q 
mice. To better clarify the T cell contribution to B cell 
phenotype in Rag2R229Q mice, we treated mutant mice with 
the  anti-CD4  mAb  (GK1.5)  for  7  wk.  This  treatment   
resulted  in  a  complete  depletion  of  circulating,  splenic,   
and BM CD4+ T cells (Fig. 5 A). Concomitant to the de-
pletion of CD4+ T cells, we observed a significant reduc-
tion of the frequency of IgG and IgA but not IgM-secreting 
cells in the spleen and BM of treated mice (Fig. 5 B), corre-
lating with the serum Ig levels (Fig. 5 C). Anti-CD4 treat-
ment determined  a  complete  normalization  of  the  IgE 
Figure 4.  Characterization of effector  
T cell subsets in Rag2R229Q mice. (A) Cyto-
kine production profile of splenic CD4+ T cells. 
Total splenocytes were stimulated for a total 
of 5 h in the presence of PMA and ionomycin. 
Cytokine production was assessed by flow 
cytometry with intracellular staining. Plots are 
gated on CD4+ T cells. Numbers indicate the 
percentage of cells in the respective quad-
rants. Data represent one of the three inde-
pendent experiments with consistent results. 
(B) Serum levels of IL-21 (WT, n = 30; 
Rag2R229Q, n = 50) and IFN- (WT, n = 30; 
Rag2R229Q, n = 50) cytokines in WT and 
Rag2R229Q mice (8–24 wk old) as analyzed by 
ELISA in three independent experiments.  
(C) Expression of CXCR5 and ICOS by CD4+ 
splenic T cells from WT and Rag2R229Q mice. 
Numbers in quadrants indicate percentage of 
cells in each. (D) Expression of indicated mol-
ecules in sorted splenic CD4+ T cell population 
assessed by qRT-PCR. Samples were run in 
duplicate, and the target mRNA was normal-
ized to Ppia mRNA. The RNA contents are 
shown as arbitrary units (A.U.). Means ± SD  
of six mice/group. Data represent one of  
the three independent experiments with con-
sistent results. *, P < 0.05; **, P ≤ 0.01;  
***, P ≤ 0.001.JEM VOL. 207, July 5, 2010 
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Ig production. Analysis of Ig in the supernatants at day 4 of 
culture indicated that mutant B cells were able to switch and 
secrete Ig at a rate comparable to control B cells, and partic-
ularly upon CpG stimulation (Fig. 7 C). To confirm in vivo 
the T cell–independent humoral responsiveness of Rag2R229Q 
B cells, we immunized mutant mice i.p. with a mixture of 
pneumococcal antigens (Pneumovax23-P23) and monitored 
total and specific IgM serum antibodies at different time 
points after immunization (from day 10 to 60). The increase 
in total and specific serum IgM was lower in Rag2R229Q with 
respect to WT littermates (Fig. 8, A and B). However, in the 
Rag2R229Q B220+ population we detected a higher frequency 
of ISC secreting P23-specific IgM which decayed rapidly 
(Fig. S5, C and D). The possible homing of specific ISC in 
the BM was excluded by the failure to detect P23-specific 
ISC in the BM of mutant mice (unpublished data). The ap-
parent discrepancy between ELISpot results and serum titers 
could be explained by considering the markedly reduced 
size of the splenic B cell compartment in mutant mice. Low 
absolute numbers of P23-specific IgM ISC would be unable 
to determine WT antibody titers. Moreover, Rag2R229Q dis-
played a more rapid decrease in specific serum antibodies 
reaching the pre-boost level at day 20, indicating a selective 
impairment in the generation of long-term humoral re-
sponses (Fig. 8, A and B). Collectively, our results show that 
Rag2R229Q mice are able to mount short-term specific hu-
moral immune responses, which do not require T cell help 
for their generation.
that the observed absence in IgG production resulted from an 
impaired generation of specific antibody-secreting cells.
Humoral response to TLR agonists and T cell–independent 
antigen in Rag2R229Q mice
It is well established that Toll-like receptor (TLR)–mediated 
activation of mature B cells is required for eliciting humoral 
immune responses (Pasare and Medzhitov, 2005). Mature 
murine B cells can be stimulated in vitro by LPS or CpG 
(the TLR4 and TLR9 ligand, respectively) to proliferate and 
secrete antibodies (Watson, 1979; Krieg et al., 1995). We 
evaluated the expression of TLR4 and TLR9 by real-time 
PCR in purified Rag2R229Q B220+ cells, and found a reduc-
tion in comparison to WT cells (Fig. 7 A). Moreover, 
Rag2R229Q B220+ cells did not cycle in response to LPS or 
CpG and IL-4 co-stimulation (Fig. 7 B). Because proper in-
terpretation of these results could be hindered by the hetero-
geneity of the B220+ cell subset, we also evaluated the   
Figure 5.  CD4 T cells sustain ISC differentiation in Rag2R229Q mice. 
Rag2R229Q mice (5 wk-old) were injected i.v. with two doses of anti-CD4 
mAb (0.25 mg/mouse) 3 wk apart and were analyzed after 7 wk. (A) Rep-
resentative FACS plots of CD4 and CD8 stainings in treated mice and con-
trols. (B) ISC by ELISpot assay. Data represent the mean ± SD number of 
spots obtained from n = 5–6 mice/group analyzed and normalized to  
105 B220+ cells. Serum Ig (C) and cytokine (D) levels in treated and control 
mice. Data represent the mean ± SD of concentrations observed in  
n = 5–6 mice/group analyzed. *, P < 0.05; **, P ≤ 0.01.
Figure 6.  Rag2R229Q mice fail to induce specific humoral response 
to OVA. WT and Rag2R229Q mice were immunized into the footpad with 
OVA emulsified in CFA and boosted at day 21 in IFA. PBS was injected in 
control mice. Total IgG1 (A) and anti-OVA–specific IgG (B) antibody titers 
were determined at days 26, 33, and 48 after challenge by ELISA. Each 
point represents mean values + SD from n = 3–4 mice and were corrected 
for background binding. Frequency analysis of total (C) and specific (D) 
ISCs by ELISpot assay on splenocytes from WT and Rag2R229Q mice at the 
indicated times after OVA challenge. Data represent the mean ± SD num-
ber of spots obtained from n = 3–4 mice/group analyzed in two indepen-
dent experiments and normalized to 105 B220+ cells. n.d., not detectable. 
CTL, PBS-treated control mice. *, P < 0.05; **, P ≤ 0.01.1532 B cells in the pathogenesis of Omenn syndrome | Cassani et al.
Rag2R229Q mice. Nonetheless, a direct 
role of B cells in the disease pathogen-
esis was suggested by the severe glom-
erulus infiltration of IgM+ and IgG+ 
cells (Fig. 9 A, top) in mice with high proteinuria index, 
whereas no tissue infiltration was observed in nonproteinuric 
mice  (Fig.  9  A,  bottom).  To  further  investigate  whether   
autoantibody production might contribute to the autoim-
mune phenotype, we screened a large cohort of Rag2R229Q 
and  control  animals  for  the  presence  of  anti–double- 
stranded DNA (anti-dsDNA) measured by ELISA and IFA 
with Chionodoxa luciliae, two complementary assays for detec-
tion of DNA autoantibodies characterized by low and high 
specificity, respectively. We observed a significant increase in 
the frequency of sera positive for both IgG and IgM specific 
for dsDNA in the group of mutant mice as compared with 
WT (P < 0.01; Fig. 9 B and not depicted). Notably, high ti-
ters of IgG anti-dsDNA were detected in animals with severe 
kidney infiltrations and urine protein loss (unpublished data). 
Staining of frozen sections of multiple organs from Rag2/Il2rc 
double knock-out mice (devoid of endogenous Ig) with sera 
derived  from  mutant  mice  confirmed  the 
presence of autoreactive Ig targeting differ-
ent tissues (Fig. 9 C).
B cells from Rag2R229Q mice actively participate to  
tissue damage
A proportion of Rag2R229Q mice spontaneously develop se-
vere  alopecia,  skin  erythrodermia,  and  wasting  syndrome 
caused by colitis (Marrella et al., 2007). In addition, a minor-
ity of them presented with differing degrees of renal damage, 
resulting in proteinuria. A marked infiltration of oligoclonal 
activated T lymphocytes was consistently evident in different 
tissues of mutant mice and correlated with abnormal CXCL10 
serum level (P = 0.002; Fig. S6 A). Further characterization 
of these infiltrates revealed that they were also composed of 
B220+ Ig+ B cells (Fig. 9 A; Fig. S6, B and C). The abun-
dance of B220+ and IgM+ cell infiltrates was lower with re-
spect to CD3+ T cells (P = 0.048 and P = 0.0098, respectively; 
Fig. S6 C), which may reflect the absence of circulating   
B cells, as well as the significantly lower representation of   
B lymphocytes in primary and secondary lymphoid organs of 
Figure 7.  Rag2R229Q mice have impaired 
proliferative responses to TLR agonists but 
intact Ig responses. (A) Splenic B220+ lym-
phocytes were purified by cell sorting, and the 
relative mRNA levels of TLR4 and TLR9 expres-
sion were determined by RT-PCR. The samples 
were run in duplicates. The obtained values 
were normalized to 18S rRNA and indicated 
as arbitrary units (A.U.). Mean values ± SD of 
three independent experiments testing eight 
mice/group. (B) Total splenocytes were CFSE 
labeled, and then stimulated in vitro with LPS 
(10 µg/ml) and CpG (2.5 µg/ml) in the absence 
or presence of IL-4 (10 ng/ml). CFSE dilution 
was analyzed by FACS at day 4 of culture. 
Representative FACS histograms of CFSE pro-
file in B220+ cell gate are shown (percentage 
is reported above the gate). The histogram 
plot is representative of three independent 
experiments (C) In parallel, Ig levels were 
measured in the culture supernatants. Ig con-
centrations were normalized for the number 
of B220+ cells in the culture. *, P < 0.05.
Figure 8.  Rag2R229Q mice show short-term  
humoral response to Pneumovax23. WT and 
Rag2R229Q mice were immunized i.p. with P23. PBS 
was injected in control mice. Total (A) and anti-P23–
specific IgM (B) antibody titers were determined at 
different days after challenge by ELISA. Each group 
represents mean values ± SD from n = 5 mice and 
were corrected for background binding. The data are 
representative of two independent experiments.JEM VOL. 207, July 5, 2010 
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antibody gene rearrangements, usually involving the  and  
light chain gene loci. Repeated variable joining rearrange-
ments eventually lead to exhaustion of the recombination po-
tential at the Igk-V gene locus and expression of a  light chain. 
A markedly reduced frequency of  chain+ B220+ cells was 
observed in mutant mice (1.5 ± 1% vs. 4.7 ± 1.6%; P = 0.0002; 
Fig. 9 D), thus suggesting that Rag2R229Q mutation impairs the 
process of secondary recombination. In normal conditions, pe-
ripheral self-reactive B cells compete with non–self-reactive   
B cells for survival factors. BAFF is the key regulator of B cell 
homeostasis beyond the late transitional B cell stage (Meyer-
Bahlburg et al., 2008), when expression of BAFF-R is acquired 
on B cells. Because increased BAFF levels are expected in mice 
with reduced B cell numbers (Lesley et al., 2004; Lavie et al., 
2007), we measured BAFF serum levels in our model. Signifi-
cantly,  higher  levels  of  BAFF  were  already  detected  in 
Rag2R229Q mice (P < 0.0001; Fig. 9 E) early in life (5-wk-old 
animals), whereas in WT mice the increase in BAFF serum 
levels was age-dependent (Fig. S6 D).
Effect of BAFF-BAFF-R signaling blockade  
in Rag2R229Q mice
As BAFF promotes B cell survival, its overexpression could 
potentially break B cell tolerance by rescuing self-reactive   
B cells from deletion. Indeed, mice transgenic for Tnfsf13b (the 
gene encoding BAFF) develop severe autoimmune symptoms 
(Mackay et al., 1999; Lesley et al., 2004; Thien et al., 2004). 
Based on this evidence, we speculated that increased BAFF   
serum levels in Rag2R229Q mice could play a crucial role in   
B cell–mediated autoimmunity by favoring the survival and 
differentiation of autoreactive ISCs. To directly test this hy-
pothesis, we examined the in vivo effect of selective BAFF-
BAFF-R signaling blockade. Mutant mice displaying an overt 
pathological phenotype (i.e., presence of serum anti-dsDNA 
IgG and proteinuria) were i.v. injected with three 0.5-mg 
doses of anti–BAFF-R mAb (9B9) known to prevent BAFF 
binding (Rauch et al., 2009), and followed for 2 mo. Rag2R229Q 
mice treated with anti–BAFF-R mAb showed a significant de-
crease in the number of splenic B220+ B cells compared with 
PBS-treated (control) animals (P = 0.008; Fig. 10 A). In WT 
mice, administration of anti–BAFF-R resulted in 90% deple-
tion of FO B cells and 68% depletion of MZ B cells (unpub-
lished data). Interestingly, a marked reduction of both CD4 
and CD8 T cells was observed in mutant, but not WT mice, 
consistent with the role of BAFF signaling on activated T cells 
(Mackay and Leung, 2006; unpublished data).
The frequency of IgM, IgG, and IgA-ISC in the spleen   
was not significantly different in treated versus control mutant 
mice, but because of the smaller splenic B cell counts, the total 
number of ISC was significantly lower in anti–BAFF-R–
treated Rag2R229Q mice than controls (P < 0.001; Fig. 10 B and 
not depicted). After euthanization, histological examinations 
were performed and the degree of cell infiltration was scored 
in different organs (liver, gut, lung, kidney, and skin). Re-
markably, a significantly decreased infiltration index was gen-
erally observed in Rag2R229Q anti–BAFF-R–treated mice 
These findings are indicative of defaults in B cell selection 
and tolerance. Receptor editing is the mechanism by which   
B lymphocytes alter their antigen receptors through secondary 
Figure 9.  Residual autoreactive B cells in Rag2R229Q mice contrib-
ute to tissue damage in autoimmune-like manifestations. (A) Char-
acterization of kidney infiltrates and correlation with clinical symptoms. 
Kidney sections from a mouse with proteinuria (score 4: ≥ 2000 mg/dl; 
top) and a mouse without renal disease (bottom). Kidneys from mice with 
proteinuria show infiltrates positive for staining with CD3, B220, IgM and 
IgG. Bars: (left) 100 µM; (middle) 50 µM; (right) 60 µM. (B) The presence 
of IgG anti–double-strand DNA autoantibodies was analyzed in the sera 
of WT (n = 70) and Rag2R229Q (n = 97) mice by ELISA and IFA in five inde-
pendent experiments. Bars indicate the frequency of positive sera in mice 
aged 8–24 wk. (C) Ig targeting tissues are detected in the sera of 
Rag2R229Q mice. Frozen sections obtained from, gut, thyroid, and adrenal 
gland of Rag2/Il2rc double-KO mice were incubated with sera obtained 
from WT and Rag2R229Q mice. Staining with anti–mouse IgG Ab followed 
by incubation with secondary, anti–mouse IgG peroxidase-conjugated 
antibody was performed. Representative images from 1 out of 10 mice 
tested/group. Bars, 100 µM. (D) FACS analysis of  light chain expression 
in gated B220+ IgM+ cells. Results are representative of 11 mice/group 
analyzed in three independent experiments. (E) Serum BAFF in Rag2R229Q 
(n = 26) and WT littermates (n = 15), measured by ELISA in two indepen-
dent experiments. **, P ≤ 0.01; ***, P ≤ 0.001.1534 B cells in the pathogenesis of Omenn syndrome | Cassani et al.
antibodies was detected in the majority of the treated mice 
(Fig. 10 D). Overall, these results support a causative role of   
B cells in the Rag2R229Q immunopathology, providing prelimi-
nary evidence for a potential therapeutic application of BAFF-
BAFF-R signaling blockade.
DISCUSSION
In this study, we have exploited Rag2R229Q mice, which repro-
duce the immunopathology observed in OS patients, to ad-
dress whether B cells play any role in the pathogenesis of the 
disease. The impairment of early B cell development in 
Rag2R229Q mice determines a dramatic reduction of the periph-
eral B cell compartment, which is characterized by the pres-
ence of Ig-negative precursors and only 
a few IgM+ IgD– B cells, which express 
several activation markers. FO B cells 
were  almost  undetectable,  whereas 
splenic MZ B cells were barely present. 
In contrast, mutant animals contained 
an expanded CD21–CD23–IgM– lym-
phocyte  population.  This  phenotype 
could be reminiscent of mice with de-
fective B cell development caused by 
lack of the surrogate light chain. In 
fact, these mice displayed an expanded 
B220+CD21–CD23–IgMlow cell subset 
and  produced  ANAs  upon  in  vitro 
polyclonal  stimulation  (Harfst  et  al., 
compared with controls, and specifically in the extent of infil-
trating B220+ and IgM+ B cells (Fig. 10 C). The potential clin-
ical effect of anti–BAFF-R administration was also evaluated. 
The Rag2R229Q mice studied manifested similar proteinuria 
levels at the beginning of treatment, which significantly wors-
ened over time in mice treated with PBS (P = 0.04; Fig. 10 D). 
In contrast, stabilization of kidney disease was observed in anti–
BAFF-R–treated mice, with 4/7 mice displaying a reduction in 
the proteinuria index (Fig. 10 D). Consistently, the treated 
mice had markedly reduced signs of glomerular damage com-
pared with the control mice that showed mesangial cell prolif-
eration and heavy deposition of IgG (Fig. 10 D). Furthermore, 
2 mo after treatment, the disappearance of IgG anti-dsDNA 
Figure 10.  Effect of anti-BAFF-R mAb 
administration in Rag2R229Q mice. Mutant 
mice were treated with three doses of 0.5 mg 
anti–BAFF-R mAb or PBS, and followed for a 
total period of 2 mo. (A) Splenic B220+ cell 
counts. (B) Absolute numbers of splenic ISC. 
Mean values ± SD obtained from n = 6–7 
mice/group. (C) The global and cell-specific 
(CD3+, B220+, IgM+) degree of infiltration was 
scored in different organs (liver, kidney, lung, 
and gut) from anti–BAFF-R mAb and PBS-
treated mice. Bars indicate the mean ± SD 
infiltration index calculated for all the organs 
from n = 6–7 mice/group. Images show im-
munostains of gut and liver from representa-
tive PBS and anti–BAFF-R mAb-treated mice. 
Bars: (left) 200 µM; (right) 50 µM. (D) The 
presence of high-affinity IgG anti-dsDNA 
autoantibodies was analyzed in the sera of 
PBS and anti–BAFF-R Rag2R229Q mice by IFA, 
before and after the treatment. Bars indicate 
the frequency of positive sera. Proteinuria was 
assessed before and after treatment of 
Rag2R229Q mice with PBS and anti–BAFF-R, 
respectively. Mean values ± SD of proteinuria 
index in n = 6–7 mice/group. (bottom) Repre-
sentative images of glomeruli from untreated 
proteinuric mice and anti-BAFFR–treated 
mice. Bars, 50 µM.JEM VOL. 207, July 5, 2010 
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that T cell help for B cells was not dependent on cognate   
interaction, as Rag2R229Q mice were severely impaired in the 
antibody response to TD antigens. The lack of OVA-specific 
IgG production might be caused by impaired T-B cell col-
laboration in the absence of GC-like structures. On the other 
hand, in this issue, Walter et al. show that adoptive transfer   
of WT CD4+ T lymphocytes was unable to correct defec-
tive antibody response to TNP-KLH, indicating B cell in-
trinsic abnormalities.
In Rag2R229Q mice, a skewed pattern of cytokines expres-
sion and T helper cell bias may favor B cell–mediated auto-
immunity. Dysregulated TFH cells produce large amounts of 
IL-21, which promotes B cell activation as well as secretion of 
pathogenic  anti-dsDNA  autoantibodies  and  contributes  to 
chronic T cell–mediated autoimmune inflammation by the 
generation of Th17 cells. Interestingly, it has been shown that 
IL-17 acts in synergy with BAFF in supporting B cell prolifer-
ation and differentiation to plasma cells in SLE patients (Hutloff 
et al., 2004; Iwai et al., 2003). In our model, homeostatically 
proliferating T cells are critical for the generation of ISCs, as 
well as the induction of the hyper-IgE state in mutant mice, 
and most likely contribute toward the pathogenesis of distinc-
tive OS clinical features.
On the other hand, autoimmunity develops to the same 
extent in T cell–sufficient and T cell–deficient BAFF-transgenic 
mice (Groom et al., 2002), indicating that BAFF-mediated 
rescue of self-reactive B cells may be T cell independent. 
High-affinity anti-dsDNA serum IgG autoantibodies to-
gether with severe kidney damage with proteinuria, which 
we observed in Rag2R229Q mice, are pathognomonic signs of 
B cell–mediated autoimmunity (Sobel et al., 1991; Manson 
et al., 2009). In the hypomorphic Rag1 murine model de-
scribed by Walter et al. (2010), only low-affinity IgG auto-
antibodies were detected and the majority of the mice were 
devoid of clinical symptoms. This variability in clinical phe-
notype may reflect the different impact of the genetic defect 
on the recombination activity and the contribution of envi-
ronmental factors.
Fewer B cells expressing  chain in the mutant mice is 
suggestive of defects in the secondary rearrangements (Vela   
et al., 2008). Because an impairment in this process would also 
affect autoreactive Ab-expressing B cells, which could not 
therefore be silenced by light chain editing, it can be specu-
lated that hypomorphic Rag2 mutation leading to impaired 
RAGs activity limits the potential to edit autoimmune BCRs. 
Under physiological conditions, self-reactive B cells that es-
cape deletion and receptor editing, compete with nonautore-
active  B  cells  for  peripheral  survival  signals.  Among  these 
signals, BAFF has a crucial role in controlling peripheral B cell 
homeostasis (Mackay et al., 2003). In Rag2R229Q mice in-
creased BAFF serum level is likely a consequence of the B cell 
lymphopenic environment (Lesley et al., 2004; Lavie et al., 
2007). It has been shown that increased BAFF levels favor the 
persistence of self-reactive B cells normally deleted at devel-
opmental checkpoints (Lesley et al., 2004; Thien et al., 2004). 
Indeed, high levels of BAFF have been detected in the serum 
2005; Keenan et al., 2008). Based on this, it can be speculated 
that in Rag2R229Q mice most of the peripheral B cells carry   
autoreactive potential.
The analysis of a large cohort of mutant mice revealed, in 
some animals, a normal or even higher Ig production com-
pared with WT mice. This variability, resembling the clinical 
phenotype reported in OS patients (Villa et al., 2001), is ac-
tually greater than the one previously reported by Marrella   
et al. (Marrella et al., 2007). Such a discrepancy could likely 
reflect the mixed genetic background of our model and the 
effects of stochastic events occurring during B cell repertoire 
generation. In mutant mice, the residual serum Ig production 
is maintained by an enlarged ISC compartment. Excessive 
commitment to plasma cell fate is sustained by a defined tran-
scription program. The observed increase in Blimp1 likely 
leads to cessation of cell cycling activity in Rag2R229Q B cells 
(Lin et al., 1997), repression of genes required to establish 
GC  reactions,  and  induction  of  the  Ig  secretory  pathway 
(Shaffer et al., 2002; Shaffer et al., 2004). Our findings corre-
late with previous observations in immunodeficient and/or 
irradiated hosts, reconstituted with a limited number of pe-
ripheral B cells (Agenès and Freitas, 1999). In these animals, 
B cells quickly expanded, displayed an activated phenotype, 
and gave rise to an increased proportion of plasma cells. 
Hence, a compensatory homeostatic regulation might account 
for the skewed B cell phenotype in our model. During inflam-
mation Aid and Blimp1 expression can be induced in imma-
ture/T1 B cells by TLR engagement in a T cell–independent 
manner (Ueda et al., 2007). Consistently, Aid+ immature/T1 
B cells were preferentially found outside the conventional 
GC, at sites exposed to exogenous antigens (Wang et al., 
2000; Ueda et al., 2007). The most severe inflammatory and 
autoimmune-like manifestations in Rag2R229Q mice affect or-
gans like the gut and the skin, where exposure to microbial 
antigens could potentially select immature B cell clones for 
expansion and antibody production. We showed that B cells 
from Rag2R229Q mice efficiently responded to TLR ligands 
and polysaccharides Ag by undergoing rapid plasmacytic dif-
ferentiation and Ig class switching. The limited variability 
consequent to impaired recombinase activity and the stochastic 
nature of B cell repertoire generation might represent factors 
determining the phenotypic heterogeneity of OS patients.
Several experiments in this study addressed the role of   
T cells in B cell homeostasis in Rag2R229Q mice. We found 
that CD4 T cells were required for B cell activation and dif-
ferentiation to plasmablasts in Rag2R229Q mice. We provided 
evidence that the dominating T cell subsets in mutant mice, 
namely Th1, Th17, and TFH cells do have a crucial role in   
B cell abnormalities. In fact, anti-CD4 treatment caused a 
significant reduction of ISC compartment and a normaliza-
tion of serum IgE. These results correlated with the decreased 
serum concentration of cytokines involved in CSR such as 
IFN- and IL-21. Interestingly, IL-21 has recently been re-
ported to stimulate IgE synthesis in humans, thus highlighting its 
important role in the occurrence of allergic and atopic dis-
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Flow cytometry and cell sorting. Mononuclear cells from the periph-
eral blood and BM of patients were labeled with the following antibodies: 
anti–human-CD19, CD24, CD38, CD22 (BD); SmIgM, SmIgD, CyIgM   
(Kallestad/Sanofi-Synthelabo). Cell suspensions from murine BM, spleens, 
and LNs were stained in PBS 2% FCS-containing antibodies. To reduce 
nonspecific binding, cells were pretreated with anti-CD16 (BD). The fol-
lowing anti–mouse antibodies were purchased from eBioscience: B220, 
CD5, CD21, CD23, BP-1, CD40L, and PD-1. Reagents purchased from 
BD include: IgM, IgD, MHCII, CD40, ICOS, CD69, CD80, CD86, 
AA4.1, Mac-1, CD4 (RM4-5 and GK1.5), CD138,  chain, HSA, strepta-
vidin, and appropriate isotype controls. Anti–mouse-CD43 and CXCR5 
were obtained from BioLegend. To detect cytokines production by T cells, 
splenocytes were cultured for 5 h with PMA (50 ng/ml), ionomycin (1 µg/
ml), and monensin (1 µg/ml; Sigma Aldrich), and then intracellular IFN-, IL-4,   
IL-10, and IL-17 were stained according to the manufacturer’s instructions 
(BD). Samples were acquired on a FACSCanto II system (BD) and analyzed 
with FLOWJO software (version 4.5.4; Tree Star Inc.). Splenic B lympho-
cytes (B220+) used for mRNA analyses were sorted with a FACSAria (BD). 
The purity was >95%.
ELISA and ELISpot. Levels of IgG isotypes, IgA, and IgM were measured 
in culture supernatants and sera by multiplex assay kit (Beadlyte Mouse Immu-
noglobulin Isotyping kit; Millipore) according to the manufacturer’s instruc-
tions and run using a Bio-Plex reader (BioRad Laboratories). Levels of IgE 
were determined by ELISA assay (BD). Cytokine and chemokine levels in su-
pernatants and sera were measured with specific ELISA kits for mouse BAFF, 
IL-21, IFN-, and CXCL10 (R&D Systems). ISCs were analyzed by ELISpot 
using the species-specific purified and biotinylated anti-IgG, IgM, IgA, and IgE 
mAbs (Southern Biotech) and the 3-amino-9-ethylcarbazole (Sigma-Aldrich) 
as a chromogenic substrate.
Determination of auto-antibody profile. For anti-dsDNA, 1:10 diluted 
serum was applied to fixed C. luciliae slides (Antibodies Inc.), with biotin- 
conjugated goat anti–mouse IgG (Southern Biotech), and Alexa Fluor 555–
conjugated streptavidin (Invitrogen) as detection reagent. A reader blinder to 
the genotype/treatment of the mice read slides at 1,000×. Anti-dsDNA anti-
bodies were also evaluated by ELISA assay. In brief, polystyrene plates were 
coated with poly-L-lysine (Sigma-Aldrich) and DNA from calf thymus 
(Sigma-Aldrich); after post coating with 50 µg/ml of Polyglutamic Acid for   
45 min and blocking with PBS 3% BSA, serial dilutions of serum from 1:20 to 
1:1,280 were incubated overnight. Bound Abs were detected with alkaline 
phosphatase-conjugated goat anti–mouse IgG (Southern Biotech). The score 
of positivity was assigned to sera that were positive for dilution of 1:20 or 
higher. For anti-cardiolipin antibodies, polystyrene plates were coated with   
50 µg/ml of cardiolipin diluted in ethyl alcohol.
Autoantibodies against murine tissues were detected by indirect immu-
nohistochemistry on cryostat tissue sections from adult Rag2/Il2rc/ mice 
to avoid interference from endogenous Ig, and stained with 1/20 dilutions 
of sera from Rag2R229Q mice and control littermates. Slides were examined 
on a Zeiss Axioplan-2 microscope and images were acquired by Olympus 
DP70 camera using CellF imaging software (Soft Imaging System GmbH).
Functional in vitro assay. Total splenocytes were labeled with 0.5 µM 
CFSE (Invitrogen) for 8 min at room temperature. After quenching the   
labeling reaction by adding FCS, cells were washed twice. Labeled cells   
(105 cells) were cultured in a 96-well U-bottomed plate with the following 
stimuli: 2.5 µg/ml CpG-B oligodeoxynucleotide (5-tccatgacgttcctgacgtt-3; 
Alexis Co.), 10 µg/ml LPS (R&D Systems), and 10 ng/ml IL-4 (R&D Sys-
tems). The proliferation profile of propidium iodide-negative viable B220+ 
cells was analyzed at day 4 of culture. On the same day, culture supernatants 
were collected for Ig quantification.
Histology. Formalin-fixed paraffin-embedded tissue sections from inguinal 
LN biopsies of OS patients and patients with unrelated nonimmunological 
diseases were subjected to routine hematoxylin and eosin (H&E) and double 
of patients with various autoimmune conditions (Zhang et al., 
2001; Groom et al., 2002; Lindh et al., 2008). In Rag2R229Q 
mice high levels of serum BAFF might rescue autoreactive 
clones and favor their differentiation to ISC. We showed that 
blocking of BAFF-BAFF-R signaling in Rag2R229Q mice with 
an anti-BAFF-R monoclonal antibody led to the disappear-
ance of anti-dsDNA IgG antibodies, a significant amelioration 
of inflammatory infiltrates and an arrest of renal disease pro-
gression. Thus, these data strongly suggest that B cell abnor-
malities and increased BAFF serum levels play a significant 
role in autoimmune manifestations in Rag2R229Q mice. Walter 
et al. (2010), in the companion paper, also measured elevated 
serum BAFF levels and autoantibody production in a large 
proportion of patients with OS and leaky SCID caused by 
hypomorphic rag mutations. Based on the results presented in 
this study, we propose that defects in B cell differentiation and 
function actively contribute to the OS pathogenesis. In sup-
port of this hypothesis, we reported the presence of terminally 
differentiated plasma cells in the lymphoid organs of OS pa-
tients devoid of circulating B cells. The similarities between 
murine and human studies validate the Rag2R229Q model for 
further investigation on the contribution of B cell defects to 
autoimmunity. In conclusion, we have shown that hypo-
morphic rag mutations do not only result in profound impair-
ment of B cell development but are also associated with the 
generation of an autoimmune BCR repertoire. We showed 
that the peripheral cytokines milieu crucially influences the 
generation of ISC and B cell–mediated immunopathology. 
The contribution of B cells to autoimmune pathology could 
provide the basis for a potential use of B cell–directed inter-
vention in OS treatment.
MATERIALS AND METHODS
Patients and cells. Six unrelated patients with hypomorphic RAG defects 
whose clinical, immunological, and molecular features were consistent with 
OS were studied (Table S1). Human samples were collected after signed in-
formed consent in accordance with the protocols of Spedali Civili of Brescia 
and Erasmus MC Ethical Committees. Mononuclear cells from peripheral 
blood and BM were purified on Ficoll gradient (Nycomed Pharma A/S).
Mice treatment and immunization. 129Sv/C57BL/6 knock-in Rag2R229Q 
mice were previously generated (Marrella et al., 2007), and housed in specific 
pathogen–free facilities. Immunizations were performed in mice aged 2–3 mo. 
T cell–dependent antigen response was induced by footpad injection of   
100 µl of a 1:1 emulsion of CFA and 100 µg OVA (grade V; Sigma-Aldrich). 
Secondary response was elicited by boosting with 50 µg OVA in IFA (Sigma-
Aldrich). T cell–independent antigen response was induced by i.p. injection 
of 115 µg Pneumovax-23 (Merck). For CD4+ T cell depletion, mice were 
injected i.v. with two doses of GK1.5 (0.25 mg) 3 wk apart and followed for 
a total of 7 wk. Anti–BAFF-R (9B9) mAb treatment was performed in mice 
(3–5 mo age) previously tested for serum autoantibody and urine proteinuria. 
3 doses of 0.5 mg were administered i.v. at 3 wk intervals. The mice were 
followed for 2 mo. In all experiments control mice were injected with PBS. 
All procedures were performed according to protocols approved by the Insti-
tutional Animal Care and Use Committee of the San Raffaele Scientific In-
stitute (IACUC318).
Proteinuria  evaluation. Proteinuria was evaluated using Albustix stick 
(Bayer). Proteinuria index was scored as follows: 0 < 30 mg/dl; 1 = 30 mg/dl; 
2 = 100 mg/dl; 3 = 300 mg/dl; and 4 ≥ 2,000 mg/dl.JEM VOL. 207, July 5, 2010 
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8 U RNAsin (Promega). Synthesis of cDNA was performed in the 96-well 
plates used for sorting in a total volume of 15 µl containing random hexamer 
primers (5 µM; Roche), NP-40 (0.3% vol/vol; Sigma-Aldrich), 10 mM 
DTT, 36 U RNAsin, dNTPs (833 µM of each nucleotide; Invitrogen), and 
50 U SuperScript III reverse transcription (Invitrogen). Reverse transcription 
was performed at 42°C for 5 min, 25°C for 10 min, 50°C for 60 min, and 
94°C for 5 min. A semi-nested PCR strategy was used for amplification of Igh 
transcripts from single cells. First round PCR was performed in a total volume 
of 40 µl, containing 3.5 µl product of the RT reaction, msVHE and mCh-
mu-outer primers (150 nM each), dNTPs (250 µM of each nucleotide), and 
1 U HotStar Taq Polymerase. The reaction was performed for 50 cycles at 
94°C for 30 s, 56°C for 30 s, and 72°C for 55 s. Second round PCR was per-
formed in a total volume of 40 µl, containing 3.5 µl product of the first round 
reaction, msVHE and mCh-mu-inner primers (150 nM each), dNTPs (250 µM 
of each nucleotide), and 1 U HotStar Taq Polymerase. The reaction was per-
formed for 50 cycles at 94°C for 30 s, 60°C for 30 s, and 72°C for 45 s.
The primers used are as follows: msVHE, 5-GGGAATTCGAGGTG-
CAGCTGCAGGAGTCTGG-3; mCh-mu-outer, 5-AGGGGGCTCTC-
GCAGGAGACGAGG-3; mCh-mu-inner, 5-AGGGGGAAGACATTT-
GGGAAGGAC-3.
PCR products were then cloned into a pCR2.1-TOPO TA vector. 
Ligation was performed in a total volume of 10 µl with 1U T4-Ligate (Invi-
trogen), 2 µl PCR product, and 50 ng linearized vector. Competent E. coli 
TOP10F’ bacteria (Takara Bio Inc.) were transformed at 42°C with 10 µl of 
the ligation product. Colonies were screened by blue–white selection. Se-
quencing of plasmids and PCR products was performed using vector primer 
and msVHE, respectively. For analysis of bulk populations, identical nucleo-
tide sequences generated from the same PCR well were excluded from the 
analysis. The obtained sequences were analyzed using National Center for 
Biotechnology  Information  IgBLAST  (http://ncbi.nlm.nih.gov/projects/
igblast/). Sequences were assigned to the Igh-V segment yielding the highest 
score, in case of a tie between several segments, the segment using the ca-
nonical nomenclature (<Igh-V segment family>.<segment number within 
family>.<segment number within locus>; Johnston et al., 2006) was as-
signed. Because of the genetic background of the animals (BX129 or 
129XB), no discrimination between segments of the Igha (129) and Ighb (B6) 
allele were made. Igh-D segments were only assigned if they showed at least 
six matching bases. Mismatches of the obtained sequences versus the known 
germline sequence were counted as hypermutations.
RNA extraction and real-time PCR. Total RNA from sorted B220+ 
cells of pooled mice (n = 5/group) was extracted using a conventional 
TRIzol-extraction (Invitrogen), treated with 100 U/ml Dnase I (Invitro-
gen), and reverse transcribed using the High Capacity cDNA Archive kit 
(Applied Biosystems). Expression of Prmd1/Blimp1 (Mm00476128_m1), Xbp1 
(Mm  00457359_m1),  Aicda  (Mm00507774_m1),  Tlr4  (Mm00445274_m1), 
and Tlr9 (Mm 00446193_m1) was quantified using the Assay on Demand kit 
(Applied Biosystems) and TaqMan Universal PCR mastermix (Applied Bio-
systems). qPCR was performed by using an ABI 7900 and analyzed using 
SDS version 2.3 (Applied Biosystems). cMyc, Bcl-6, T-bet, RORT, Gata-3, 
and Cxcl2 expression was quantified by RT-qPCR from 50 ng cDNA in the 
presence of the TaqMan Universal PCR mastermix, 200 nM gene-specific   
TaqMan probe (Universal Probes; Roche), and 800 nM of relative primer pairs, 
using the DNA Engine Opticon 2 System (MJ Research). Thermal cycle 
conditions were the following: 95°C for 10 min, 40 cycles of 95°C for 15 s, 
and 60°C for 60 s. The primers and probes used are as follows: c-Myc,   
5-CCTAGTGCTGCATGAGGAGA-3 and 5-TCTTCCTCATCTTC-
TTGCTCTTC-3, probe #77; Bcl6, 5-TTCCGCTACAAGGGCAAC-3 
and  5-CAGCGATAGGGTTTCTCACC-3,  probe  #5  ;  T-bet,   
5-TCAACCAGCACCAGACAGAG-3 and 5-AAACATCCTGTAATG-
GCTTGTG-3, probe #19; RORT, 5-CGACTGGAGGACCTTC-
TACG-3 and 5-CCCACATCTCCCACATTGA-3, probe #52; Gata-3, 
5-TTATCAAGCCCAAGCGAAG-3  and  5-TGGTGGTGGTCTGA-
CAGTTC-3,  probe  #108;  Cxc12,  5-CTGTGCCCTTCAGATT-
GTTG-3  and  5-TAATTTCGGGTCAATGCACA-3,  probe  #41;  
immunostains. In brief, sections were de-waxed, rehydrated, and endoge-
nous peroxidase activity blocked before heat-induced epitope retrieval in   
1.0 mM EDTA buffer (pH 8.0) followed by 1 h incubation with primary 
monoclonal mouse anti–human CD138 (clone NI15, 1:100; Dako) and rat 
monoclonal anti–Blimp-1 (clone 6D3, 1:50; Santa Cruz Biotechnology Inc.) 
antibodies. Double immunostainings were obtained by combining a first step 
using the appropriate biotinylated secondary anti–rat antibody (1:100; Vec-
tor Laboratories) followed by streptavidin (SA)-conjugated HRP and diami-
nobenzidine (Dako) as chromogen, and a second step using a biotinylated 
secondary anti–mouse antibody (1:100; Vector Laboratories) followed by 
SA-conjugated alkaline phosphatase (Dako) and Ferangi Blue as chromogen 
(Biocare Medical). Nuclei were counterstained with Methyl Green.
Formalin fixed paraffin embedded murine samples (liver, kidney, skin, 
lung, and gut) were subjected to H&E staining to check for basic histopatho-
logical changes, and immunohistochemistry was performed as previously de-
scribed for human samples. Single immunostain reactivity was revealed using 
Real EnVision Mouse/Rabbit-HRP (Dako) or Super Sensitive IHC Detec-
tion System (BioGenex), followed by diaminobenzidine and nuclei counter-
stained with H&E. The following primary antibodies have been used: 
monoclonal rat anti-CD3 (clone CT-CD3; 1:100; Valter Occhiena), rat 
anti-B220 (clone RA3-6B2; 1:100; Valter Occhiena), rat anti-F4/80 (clone 
BM8; 1:25; Caltag Laboratories), and polyclonal rabbit anti-Iba-1 (1:400; 
Wako). Murine plasma cells and Ig deposits have been detected directly by 
using either an appropriate biotinylated secondary goat anti-murine IgM 
(Dako) and goat anti–murine IgG (H+L; KPL) or ChemMATE Envision 
Mouse-HRP detection system (Dako) that bind specifically to the murine 
Ig. Digital images were then acquired with Olympus DP70 camera mounted 
on Olympus Bx60 microscope using AnalySIS imaging software (Soft Imag-
ing System GmbH).
The degree of inflammation in the liver, lung, and kidney was double-
blinded scored using the following criteria: 0 (none or scarse cell infiltrates); 
1 (low to moderate); 2 (moderate to high); 3 (very high). Colitis was graded 
as follows (Scheiffele and Fuss, 2002): grade 0, no evidence of inflammation; 
grade 1, low level of leukocyte infiltration around the crypt basis in <10% 
HPF with no structural changes; grade 2, moderate infiltration in 10–25% 
HPF involving the lamina propria with minimal epithelial hyperplasia and/or 
goblet cell depletion; grade 3, high level of infiltration in 25–50% HPF reach-
ing the muscularis mucosa with bowel wall thickening, moderate goblet cell 
loss, edema, crypt elongation, and epithelial erosions; grade 4: marked degree 
of transmural infiltration in >50% HPF with massive loss of goblet cell, fibro-
sis, elongated and distorted crypts with occasional abscesses, ulcerations, and 
bowel-wall thickening.
Ig genes amplification. For bulk Igh PCRs splenic B220+ cells from WT 
and Rag2R229Q mice were sorted on a FACS Aria (BD), excluding cell dou-
blets, into 96-well PCR plates (Applied Biosystems; 50 cells/well) containing 
20 µl/well of ice-cold 0.5× PBS supplemented with 10 mM DTT, 8 U 
RNAsin (Promega), and 0.4 U 5-Prime RNase Inhibitor (Eppendorf). Plates 
were sealed and immediately frozen on dry ice before storage at 80°C. 
cDNA was synthesized in a total volume of 40 µl/well in the original 96-well 
sorting plate. The reverse transcription (RT) reaction was performed by using 
the High Capacity cDNA Archive kit (Applied Biosystems) following manu-
facturer’s instructions. cDNA was stored at 20°C. Igh transcripts were am-
plified by PCR using 3 µl of cDNA as template. All reactions were performed 
in PCR tubes in a total volume of 50 µl per well containing 100 nM of each 
primer (msVHE and mCh-mu-inner), 200 µM each dNTP (Invitrogen), and 
1.25U HotStar Taq DNA polymerase (QIAGEN). Primers were stored in 
small aliquots to avoid repeated freezing and thawing and all PCRs were per-
formed with nuclease-free water. PCR was performed for 35 cycles at 95°C 
for 30 s, 56°C for 30 s, and 72°C for 55 s. For single-cell Igh PCRs the ex-
perimental procedures have been described in detail before (Tiller et al., 
2009). In brief, single B220+CD19+ splenocytes were sorted on FACSV 
antage with DiVa option (BD), using doublet discrimination and single-cell 
sorting mask settings. Cells were sorted into 96-well plates (Eppendorf) con-
taining 4 µl of 0.5× PBS supplemented with 10 mM DTT (Invitrogen) and   1538 B cells in the pathogenesis of Omenn syndrome | Cassani et al.
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